TD SYNNEX (SNX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
3 Feb, 2026Executive summary
Annual Meeting scheduled for March 25, 2026, with proxy materials available online and voting accessible via internet, phone, or mail.
FY2025 saw $62.5B in revenue (+7% y/y), $89.4B in non-GAAP gross billings (+12% y/y), and $9.95 diluted EPS (+25% y/y).
Approximately $742M was returned to stockholders through share repurchases and dividends.
Key leadership changes included the appointment of a new CFO and a new director.
Voting matters and shareholder proposals
Election of ten directors to serve until the 2027 Annual Meeting.
Advisory vote on named executive officer compensation (say-on-pay).
Ratification of KPMG LLP as independent registered public accountants.
Charter amendment to allow stockholders owning at least 25% of common stock to call a special meeting.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of ten directors, majority independent, with diverse backgrounds and expertise.
Four women serve as directors, holding key leadership roles.
Board committees: Audit, Compensation, Nominating and Corporate Governance, and Technology.
All committee members meet NYSE and SEC independence standards.
Directors are subject to equity ownership guidelines and ongoing education.
Latest events from TD SYNNEX
- Record Q1 FY26 growth and strong Q2 outlook driven by robust demand and operational execution.SNX
Q1 202631 Mar 2026 - Strong growth, high cash conversion, and significant shareholder returns drive performance.SNX
Investor presentation31 Mar 2026 - Strong growth in IT distribution and cloud infrastructure drives robust earnings and shareholder returns.SNX
Company presentation31 Mar 2026 - Key votes include director elections, say-on-pay, auditor ratification, and a charter amendment.SNX
Proxy Filing13 Feb 2026 - Proxy covers director elections, say-on-pay, auditor ratification, and ESG progress.SNX
Proxy Filing13 Feb 2026 - Q2 delivered 3% gross billings growth, margin gains, and strong shareholder returns.SNX
Q2 20243 Feb 2026 - Q3 non-GAAP gross billings up 9% to $20.3B; revenue $14.7B; Q4 outlook strong.SNX
Q3 202420 Jan 2026 - Q4 revenue rose 10% with strong cash flow, robust capital returns, and a higher dividend.SNX
Q4 202410 Jan 2026 - Record Q4 and FY results with 15% billings growth, 24% EPS gain, and strong FY26 outlook.SNX
Q4 20258 Jan 2026